Latest news with #JeremyLim
CNA
16 hours ago
- Health
- CNA
Deep Dive Podcast: Great Eastern suspends Mount Elizabeth pre-authorisation - time to relook how health insurance is managed?
When insurer Great Eastern suspended pre-authorisation for admission to Mount Elizabeth hospitals, it raised questions about the way health insurance is managed in Singapore. With increased medical bills and insurance premiums, who is paying for what and where are the gaps? Steven Chia and Otelli Edwards speak with Associate Professor Jeremy Lim of Saw Swee Hock School of Public Health and Dr Yoong Siew Lee, a health services consultant. Here is an excerpt from the conversation: Otelli Edwards, host: Why are hospitals charging differently for the same treatment? Dr Yoong Siew Lee, a health services consultant: Different hospitals have different charges and Great Eastern will have access to the data on those charges, so the detailed bills actually show the differences. So you have surgeon fees that can be standardised with fee benchmarks. But you also have occupational therapy facility fees, you have bed charges, which vary between the hospitals. Otelli: Like a five-star bed versus a three-star bed? Dr Yoong: Versus a six-star. So the facilities are all different and that attracts different price points. Some insurers have actually dealt with that by tiering the insurance. So if you choose a certain tier of insurance, you can go to all the hospitals. Or if you choose a sub-tier, you can go to some of the hospitals and you pay a lower premium. If they pool all the hospitals, then naturally the premium will go up if everybody chooses the most expensive hospitals. Steven Chia, host: But right now we don't (pool all the hospitals), right? If you choose to adopt the private one, will you have access to all the private hospitals? Dr Yoong: No, not all insurers are like that. Insurers have different schemes for customers with different pockets. Otelli: What's the difference between choosing public versus private (hospitals)? Because in public, you can choose the class A ward or the premium as well, right? So what would you say is the main difference there? Associate Professor Jeremy Lim, Saw Swee Hock School of Public Health: Generally, the insurers don't impose a pre-authorisation on public hospitals and this includes the private wards of public hospitals, because there's a high degree of predictability in the public hospitals. Doctors' fees are pretty much set, the hospital charges for room and other services are very, very predictable and they're well within the range of what the insurers are prepared to pay. So policyholders who go to a public hospital generally find the experience pretty fuss-free, because there is a high degree of conviction amongst the insurers that the fees are going to be reasonable. Steven: Versus the private hospitals, which, you seem to be suggesting – are a bit more volatile? Assoc Prof Lim: There is much more variability (in private hospitals) because the doctors price differently, as Dr Yoong mentioned, has been attenuated by the fee benchmarks and by the negotiations that the insurers have had with the doctors.
_3.jpg%3Fitok%3DxA6GL2kf&w=3840&q=100)
CNA
16 hours ago
- Business
- CNA
Deep Dive - Great Eastern suspends Mount Elizabeth pre-authorisation - time to relook how health insurance is managed?
Play When insurer Great Eastern suspended pre-authorisation for admission to Mount Elizabeth hospitals, it raised questions about the way health insurance is managed in Singapore. With increased medical bills and insurance premiums, who is paying for what and where are the gaps? Steven Chia and Otelli Edwards speak with Associate Professor Jeremy Lim of Saw Swee Hock School of Public Health and Dr Yoong Siew Lee, a health services consultant. Deep Dive - Great Eastern suspends Mount Elizabeth pre-authorisation - time to relook how health insurance is managed? When insurer Great Eastern suspended pre-authorisation for admission to Mount Elizabeth hospitals, it raised questions about the way health insurance is managed in Singapore. With increased medical bills and insurance premiums, who is paying for what and where are the gaps? Steven Chia and Otelli Edwards speak with Associate Professor Jeremy Lim of Saw Swee Hock School of Public Health and Dr Yoong Siew Lee, a health services consultant. 25 mins Deep Dive - Jetstar Asia closure: Are the days of cheap fares over? Jetstar Asia will cease operations on Jul 31, a move unsurprising to experts because the low-cost carrier was struggling to turn a profit in a tough aviation market. Otelli Edwards speaks to Shukor Yusof from aviation consultancy Endau Analytics and Dr Nitin Pangarkar from NUS Business School to find out what the future holds. 20 mins Deep Dive - Is Singapore's electric vehicle infrastructure catching up with demand? Electric vehicle sales hit a new high in the first three months of 2025, accounting for 40 per cent of total car registrations. Yet concerns about charging networks and capacity remain. Steven Chia and Otelli Edwards speak with transport economist Walter Theseira and Stephanie Tan, CEO of EV-Electric Charging. 25 mins Deep Dive - Calling 995? You may be rerouted to the NurseFirst helpline instead – here's how it works Non-life-threatening 995 calls will be directed to NurseFirst, a triage helpline, under a six-month nationwide trial aimed at easing the burden on emergency services. How exactly does it work, and will the public adapt? Steven Chia and Otelli Edwards find out from Col Dr David Pflug, chief medical officer of the Singapore Civil Defence Force and Dr Jade Kua, clinical lead for the NurseFirst helpline and senior consultant at the emergency medicine department in Woodlands Health. 18 mins
Associated Press
13-02-2025
- Health
- Associated Press
Sequential and AMILI Secure Prestigious $1.8M UK-Singapore Collaborative R&D Project to Advance Gut-Skin Microbiome Science
LONDON, Feb. 13, 2025 /PRNewswire/ -- Sequential Skin Ltd, a world leader in skin microbiome testing, and AMILI, a leading expert in gut microbiome science, are proud to announce that they have been awarded the prestigious UK-Singapore Collaborative R&D Grant. The $1.8 million project, supported by Innovate UK and Enterprise SG, will make significant strides in characterising the interplay between the skin and gut microbiome, offering a groundbreaking approach to evaluating inflammatory skin disorders (ISDs) such as atopic dermatitis and psoriasis. Chronic and recurrent ISDs affect 20-25% of the population, significantly impacting physical and mental well-being. Research has shown that the skin microbiome plays a crucial role in disease progression, with imbalances in the gut microbiota contributing extensively to ISD development. However, current microbiome testing services analyze the skin in isolation, failing to leverage the gut-skin axis for a comprehensive understanding of skin health. Sequential has built a database of over 25,000 clinical skin microbiome samples and has pioneered the world's early skin microbiome at-home tests that were made commercially available in 2019. The previous recipient of an Innovate UK Smart Grant, with labs in US, Europe and Asia, Sequential is currently working with over 80 personal care and pharmaceutical companies innovating in the skin microbiome field. AMILI, headquartered in Singapore, has been at the forefront of gut microbiome research. Since AMILI founders performed the first gut microbiome transplants in the region in 2014, AMILI has focused on developing and deeply analysing Asia's largest multi-ethnic gut microbiome database to map the relationships and mechanistic pathways between changes in the gut microbiome and health conditions. This funding allows both organizations to accelerate their efforts in developing targeted, microbiome-driven interventions. 'We are thrilled to have won this competitive grant, which will enable us to pioneer a novel approach to further characterise inflammatory skin conditions,' said Dr. Oliver Worsley, CEO of Sequential. 'By leveraging our world-class skin microbiome dataset alongside AMILI's extensive gut microbiome research, we will be able to have a real impact by developing next generation, actionable and non-invasive at-home tests.' 'We thank both our countries for the faith in us. The gut-skin axis is a novel but clearly important dimension to improve diagnostic testing for the millions around the world afflicted with ISD and we in AMILI are delighted to work with Sequential on this exciting project' said Dr. Jeremy Lim, CEO of AMILI.
